✦ LIBER ✦

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009–2010 seasonal influenza vaccine in young patients with Type 1 diabetes mellitus

✍ Scribed by G. V. Zuccotti; E. Pariani; A. Scaramuzza; L. Santoro; E. Giani; M. Macedoni; A. Gazzarri; G. Anselmi; A. Amendola; A. Zanetti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity, safety and tolerability

✍ Susanna Esposito; Emanuela D’Angelo; Cristina Daleno; Francesco Peia; Alessia Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Safety and immunogenicity of a 2009 pand

✍ Zoltan Vajo; Ferenc Tamas; Laszlo Sinka; Istvan Jankovics 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 106 KB

Adjuvanted influenza a (H1N1) 2009 vacci

✍ Cherif, Honar; Höglund, Martin; Pauksens, Karlis 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

A clinical study to assess the immunogen

✍ Hsiang-Chi Kung; Kuo-Chin Huang; Tsui-Mai Kao; Yi-Chien Lee; Feng-Yee Chang; Nin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 630 KB

Immunogenicity and Safety of Varying Dos

✍ Jackson, L. A.; Chen, W. H.; Stapleton, J. T.; Dekker, C. L.; Wald, A.; Brady, R 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 221 KB

Immunogenicity and safety in adults of o

✍ François Roman; Tejaswini Vaman; Beatrice Gerlach; Andre Markendorf; Paul Gillar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 143 KB